Neonatal cystic fibrosis screening
Definition
Neonatal cystic fibrosis screening is a blood test that looks for increased levels of immunoreactive trypsinogen (IRT), an enzyme produced by the pancreas.
The test is performed on newborns to screen for cystic fibrosis (CF). Cystic fibrosis is an inherited disease that causes thick, sticky mucus to build up in the lungs and digestive tract
Alternative Names
Cystic fibrosis screening - neonatal; Immunoreactive trypsinogen; IRT test
How the Test is Performed
A sample of blood is either taken from the bottom of the baby's foot of a vein in the arm. A tiny drop of blood is collected onto a piece of filter paper and allowed to dry. The dried blood sample is sent to a lab for analysis.
How to Prepare for the Test
There is no special preparation needed.
Some states include this test in the routine newborn screening tests that are done before the baby leaves the hospital.
If you live in a state that does not perform routine CF screening, your health care provider will explain whether testing is needed.
How the Test Will Feel
The brief feeling of discomfort will probably cause your baby to cry.
Why the Test is Performed
Children with CF who are diagnosed early in life and start treatment at a young age may have better nutrition, growth, and lung function. Newborn screening tests allow doctors to identify children with CF before they have symptoms.
Normal Results
Normal values vary from lab to lab. Ask your doctor or testing center for details.
What Abnormal Results Mean
It is important to remember that a positive screening test for cystic fibrosis does not diagnose cystic fibrosis. If your child's test is positive, further tests will be done to confirm the possibility of CF. Not all children with a positive screening IRT test have CF.
Risks
Risks associated with the test include:
- Infection (a slight risk any time the skin is broken)
- Anxiety over false positive tests
- False reassurance over false negative tests
Considerations
The IRT level does not indicate the severity of the CF. False-positives may occur.
References
Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis consensus report. Pediatrics. Aug 2008;153(2).
Reviewed By: Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Disclaimer: The information contained in this website, and its associated websites, is provided as a benefit to the local community, and the Internet community in general; it does not constitute medical advice. We try to provide quality information, but we make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this website and its associated sites. As medical advice must be tailored to the specific circumstances of each patient and healthcare is constantly changing, nothing provided herein should be used as a substitute for the advice of a competent physician. Furthermore, in providing this service, Adventist HealthCare does not condone or support all of the content covered in this site. As an Adventist health care organization, Adventist HealthCare acts in accordance with the ethical and religious directives for Adventist health care services.
Adventist HealthCare · 301-315-3030 · 1801 Research BLVD, Suite 400, Rockville, MD 20850
Get Care
Health & Wellness
Patient Information
Website Information
Ways of Giving
